Clotrimazole + Lidocaine HydrochlorideThird Party Manufacturing in India

Clotrimazole + Lidocaine Hydrochloride works by combining an antifungal mechanism with an immediate neurological nerve block. Clotrimazole inhibits the biosynthesis of ergosterol by binding to the fungal 14-alpha demethylase enzyme, causing cell membrane leakage, while lidocaine blocks voltage-gated sodium channels along the nerve fibers to arrest pain transmission. They work in tandem to help the body eradicate fungal otic colonies while instantly relieving ear canal pain. Unlike mono-antifungals, this product provides immediate relief from agonizing itching and ache. It is highly effective and well-tolerated.

Therapeutic Uses

• Otomycosis: Indicated for treating fungal infections of the external auditory meatus caused by Aspergillus or Candida species.
• Painful Ear Canal Inflammation: Formulated to provide pain relief and anti-pruritic action during acute ear infections.

Why Manufacturers Choose Clotrimazole + Lidocaine Hydrochloride

Clotrimazole + Lidocaine Hydrochloride third party manufacturing in India is highly popular because fungal ear infections are highly prevalent in humid, tropical regions. ENT specialists widely prefer this combination because lidocaine offers instant pain relief while the antifungal takes time to eliminate the pathogen. Celesta coordinates the production via partner facilities that are WHO-GMP certified, maintaining strict anhydrous liquid configurations to prevent ingredient degradation. It is a vital and high-margin product line for specialized medical brands working under WHO-GMP compliance.